| Literature DB >> 8645963 |
J L Schilder1, J N Van den Anker.
Abstract
Treatment of hypertension with enalapril in a preterm infant is described. Enalapril is a new converting enzyme blocker with a longer plasma half-life and less side effects than captopril. Oral administration of enalapril 0.1 mg/kg caused severe hypotension and renal failure in a preterm infant. We recommend an oral starting dose of 0.01 mg/kg in preterm infants and extremely close monitoring of infants receiving the first dose of enalapril.Entities:
Mesh:
Substances:
Year: 1995 PMID: 8645963 DOI: 10.1111/j.1651-2227.1995.tb13581.x
Source DB: PubMed Journal: Acta Paediatr ISSN: 0803-5253 Impact factor: 2.299